The body’s “killer” T cells don’t just attack—they strike with astonishing precision, forming a tiny, highly organized ...
A newly identified weakness in “zombie” cells may open the door to more precise cancer treatments by turning their own ...
When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...
Cytotoxic T lymphocytes are the body's specialized "killer" cells, precisely eliminating infected or cancerous cells. Their ...
Cryo-expansion microscopy has enabled researchers to visualise the three-dimensional organisation of cytotoxic T lymphocytes ...
The first clinical trial to test the tumour-fighting power of a stem-cell-like class of long-lived immune cells suggests that ...
Morning Overview on MSN
New drugs target senescent "zombie" cells, opening a cancer pathway
Chemotherapy kills cancer cells, but it also leaves behind something troubling: damaged cells that stop dividing yet refuse ...
PHILADELPHIA.Today on MSN
Researchers from Wistar Institute, ChristianaCare identify promising new therapeutic target for pancreatic cancer
Scientists at The Wistar Institute and clinical researchers from ChristianaCare’s Helen F. Graham Cancer Center & Research ...
A collaboration between the University of Geneva and Lausanne University Hospital has shown in new detail how the body's defenses fight back against malignant cells. Those defenses involve T ...
Cancer treatment has long been haunted by the same problem: how do you strike dangerous cells without hitting healthy ones nearby? A team at the University of Geneva has built a drug-delivery system ...
At AACR 2026, scientists showcased advances in radiotherapeutics, antibody-drug conjugates, T cell engagers, and ...
Aspirin reduces the risk of colon cancer recurrence after surgery, but only in patients with a specific genetic marker ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results